Allogeneic NK immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic NK immunotherapy, covering 2020-09-14 to 2020-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors [Phase 1, Phase 2]